» Articles » PMID: 25126364

Review of Strategies to Enhance Outcomes for Patients with Type 2 Diabetes: Payers' Perspective

Overview
Date 2014 Aug 16
PMID 25126364
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Diabetes and its clinical consequences exact a great toll on patients and on society in terms of its effects on morbidity and mortality and its staggering economic impact.

Objective: To review various programs and strategies that aim at enhancing adherence to antihyperglycemic therapy and suggest the best approach to improving patient outcomes and reducing healthcare costs.

Discussion: Treatment goals for patients with diabetes have been defined, and multiple safe and effective medications are available. Nevertheless, the majority of patients with diabetes fail to achieve treatment goals, because of difficulty with adherence to medication regimens and lifestyle modifications, and because of economic barriers. This article discusses various initiatives developed to improve patient outcomes, including consumer-driven health plans and wellness and prevention programs. Furthermore, economic incentives to patients, such as value-based insurance design, may increase adherence; nevertheless, evidence suggests that such programs alone provide only modest gains. Primary providers in disease management programs can include nurses, case managers, or pharmacists. Supportive interventions across several modalities have been shown to be effective.

Conclusion: An approach that uses a combination of strategies designed to impact patients' health-related behaviors across a variety of modalities may help to improve outcomes and reduce costs. Additional novel, innovative interdisciplinary initiatives are necessary to effect meaningful change that can facilitate improved health outcomes for patients with diabetes and maximize cost-effectiveness approaches for payers.

Citing Articles

Evolution of Clinical Complexity, Treatment Burden, Health Care Use, and Diabetes-Related Outcomes Among Commercial and Medicare Advantage Plan Beneficiaries With Diabetes in the U.S., 2006-2018.

Benning T, Heien H, McCoy R Diabetes Care. 2022; 45(10):2299-2308.

PMID: 35926104 PMC: 9643151. DOI: 10.2337/dc21-2623.


The illness experience of an undocumented immigrant in the USA.

Blommel J, Chacon A, Bagatell S BMJ Case Rep. 2018; 2018.

PMID: 30323100 PMC: 6194386. DOI: 10.1136/bcr-2018-225004.


A Systematic Review of Interventions Addressing Adherence to Anti-Diabetic Medications in Patients with Type 2 Diabetes--Components of Interventions.

Sapkota S, Brien J, Greenfield J, Aslani P PLoS One. 2015; 10(6):e0128581.

PMID: 26053004 PMC: 4460122. DOI: 10.1371/journal.pone.0128581.

References
1.
Diamond F . Empowered physicians are key to diabetes program's success. Manag Care. 2009; 18(1):44-6. View

2.
Koro C, Bowlin S, Bourgeois N, Fedder D . Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care. 2003; 27(1):17-20. DOI: 10.2337/diacare.27.1.17. View

3.
Nguyen Q, Nguyen L, Felicetta J . Evaluation and management of diabetes mellitus. Am Health Drug Benefits. 2014; 1(8):39-48. PMC: 4106505. View

4.
Butcher L . Multifaceted diabetes program pays off for healthpartners. Manag Care. 2009; 18(1):36-40. View

5.
Nair K, Miller K, Saseen J, Wolfe P, Allen R, Park J . Prescription copay reduction program for diabetic employees: impact on medication compliance and healthcare costs and utilization. Am Health Drug Benefits. 2014; 2(1):14-24. PMC: 4106588. View